← SynDRA
ST1535
SynDRA canonical compound SYN0005993 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | ADORA1 | ADORA2A |
|---|
| Mechanism of action | adenosine receptor antagonist |
|---|
All known targets
- ADORA2A
- ADORA1
- ADORA2B
- ADORA3
Mechanisms of action (all sources)
- ADORA2A ANTAGONIST
- Adenosine A2a receptor antagonist
- ADORA1 ANTAGONIST
- ADORA2B ANTAGONIST
- ADORA3 ANTAGONIST
- adenosine receptor antagonist
- ADORA2B INHIBITOR
- ADORA2A INHIBITOR
- ADORA1 INHIBITOR
Cross-references
Synonyms
- Ct-1500
- St-1535
- ST 1535
- CHEMBL197669
- 2-butyl-9-methyl-8-(2H-1,2,3-triazol-2-yl)-9H-purin-6-amine
- 9H-Purin-6-amine, 2-butyl-9-methyl-8-(2H-1,2,3-triazol-2-yl)-
- 2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine
- GTPL5613
- SCHEMBL5362208
- CTK1D0597
- DTXSID60432000
- ZINC1554291
- BDBM50176058
- AKOS030562134
- SB16783
- AS-35290
- L001675
- 2-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine
- ST-1535
- NTK8WWM73W
- CT-1500
- RefChem:185246
- DTXCID20382830
- MFCD27987937
- ST 1535 - Bio-X
- orb1304889
- SCHEMBL29362910
- GLXC-05701
- 2-n-butyl-9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine
- BS165703
- DA-69749
- HY-105003
- T28861
Look up ST1535 in the interactive SynDRA portal →